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Received July 26, 2010; accepted November 2, 2010AbstractBackground: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) model is a widely-used risk prediction algorithm for
in-hospital or 30-day mortality in adult cardiac surgery patients. Recent studies indicated that EuroSCORE tends to overpredict mortality. The
aim of our study is to evaluate the validity of EuroSCORE in Veterans General Hospital Kaohsiung (VGHKS) cardiac surgery including
a number of different surgical and risk subgroups.
Methods: From January 2006 to December 2009, 1,240 adult patients who underwent cardiac surgery in VGHKS were included in this study.
The study was followed the guidelines of the Ethics Committee of Kaohsiung Veterans General Hospital, Taiwan. Both additive and logistic
score of all patients were calculated depending on the formula in the official EuroSCORE website. The entire cohort, different surgical type and
risk stratification subgroups were analyzed. Model discrimination was tested by determining the area under receiver operating characteristic
(ROC) curve. Model calibration was tested by the HosmereLemeshow chi-square test. Clinical performance of model was assessed by
comparing the observed and predicted mortality rates.
Results: There were significant differences between the VGHKS and European cardiac surgical populations. The additive score and logistic score
for the overall group were 7.16% and 12.88%, respectively. Observed mortality was 10.72% overall, 5.68% for isolated coronary artery bypass
grafting (CABG), 4.67% for the mitral valve only and 4.25% for the aortic valve only group. The discriminative ability EuroSCORE was very
good in all and various surgical subgroups, with area under the ROC curve from 0.75 to 0.87. The addictive and logistic models of EuroSCORE
showed excellent accuracy, 0.839 and 0.845, respectively. Good calibration power was recognized by p value higher than 0.05 for the entire
cohort and all subgroups of patients except for isolated CABG. The logistic EuroSCORE model overestimated mortality to different degrees in
the various subgroups, indicating that the logistic EuroSCORE needs to be recalibrated by a factor about 0.55 for uncomplicated surgery and
low-risk groups, and 0.85 for high-risk patients with original additive score more than six.
Conclusion: EuroSCORE is simple and easy to use. In the present study, the model demonstrated excellent accuracy in all and various surgical
subgroups in VGHKS cardiovascular surgery populations. Good calibration ability in all and different risk categories was identified except for
isolated CABG group. Recalibration factors of 0.55 and 0.85 were suggested for the various operative subgroups and risk categories.
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The European System for Cardiac Operative Evaluation
(EuroSCORE), developed beginning in 1995 in Europe, is
a widely-used model to evaluate in-hospital or 30-day
mortality in modern adult cardiac surgery patients. The addi-
tive EuroSCORE risk model was developed utilizing data of
17 risk factors for of 19,030 patients from 128 surgical centers
in eight European states who underwent surgery between
September and November 1995, and was published in 1999.1,2
Subsequently, the logistic EuroSCORE model was developed
to provide a better risk prediction, especially in high-risk
patients and was published in 2003.3 This model is as well the
most widely-used risk prediction algorithm in Taiwan, owing
in part to its validation with good results in Europe, North
America and Japan,4e7 and also its simplicity and bedside
applicability during pre-operative consultation with patients.
To be utilized reliably outside the countries of origins,
careful evaluation studies of the validity of the EuroSCORE
model were carried out in different countries following its
broad usage internationally. Several recent large national data
collection studies held in Australia,8 United Kingdom,9
Italy,10 China11 and Germany12 indicated that EuroSCORE
tends to overpredict the mortality risk by analyzing the ratio
between observed and expected deaths, which appears to be
more marked for the logistic form of the model. Two meta-
analysis studies also stated the same tendency of out-
performing of the logistic model.13,14 In Taiwan, a previously
performed validative study of 801 consecutive adult cardiac
surgical patients who underwent coronary artery bypass
grafting (CABG) from one institution,15 published in 2004,
showed considerably relevant result between observed and
expected mortality rates.
At present, the EuroSCORE is commonly used to identify
potentially high-risk patients who are being considered for
newly-developed transcatheter procedures such as trans-
catheter aortic valve implantation (TAVI).16 To recognize its
fitness for Taiwanese cardiovascular surgical population, this
study focused on the accuracy, calibration and clinical
performance of the EuroSCORE in southern Taiwan, including
a number of different surgical and risk subgroups.
2. Methods2.1. PatientsFrom January 2006 to December 2009, 1,240 adult patients
who underwent cardiac surgery with cardiac-pulmonary bypass
or off-pump CABG in our institution (Veteran General Hospital
Kaohsiung, Kaohsiung, Taiwan) were included in this study. The
definitions of all risk factorswere strictly according to the original
publication of Nashef et al.2 Both simple additive1 and logistic
EuroSCORE scores3 of all patients were calculated depending on
the formula in the official website (www.euroscore.org).
In addition to investigating the ability of the EuroSCORE
for different surgical type and risk stratification, we further
studied the performance in the following surgical subgroups:isolated CABG, isolated aortic valve surgery and isolated
mitral valve surgery; and four risk categories grouped by
additive score: low-risk (0e2), medium-risk (3e5), high-risk
(6e13), and very high-risk (14þ).2.2. Statistical analysisStatistical analysis was by unpaired t test for continuous
variables and chi-square test for categorical variables. A p value
under 0.05 was considered significant. Data analysis was per-
formed using SPSS 10.5 statistical software package (SPSS Inc.,
Chicago, IL, USA). Data acquisition was performed using
Microsoft Access version 2000.
Discrimination (statistical accuracy) was analyzed by
calculating the area under the curve (AUC or c-index) of the
receiver operating characteristic (ROC) curve.17 The model
was considered excellent if the area under ROC curve was
>0.80, very good if >0.75 and good if >0.70. Calibration
(statistical precision) was tested by using HosmereLemeshow
goodness-of-fit statistics, where the higher the p value was, the
better the calibration of the model.18 Clinical performance of
the EuroSCORE model was assessed by comparing the
observed and predicted mortality rates calculated by the
logistic EuroSCORE according to the mean value with 95%
confidence interval.
Multivariate logistic regression analysis was performed in
the VGHKS patient population using the same variables
according to the original publication of Rogues et al3 in 2003.
For age, Xi ¼ 1 if patient age <60; Xi increases by one point
per year thereafter (e.g. age 59 or less than Xi ¼ 1; age 60 then
Xi ¼ 2; age 61 then Xi ¼ 3 and so on).
3. Results
The prevalence of the risk factors in the two study pop-
ulations are listed in Table 1. There were significant differ-
ences between the VGHKS and European cardiac surgical
populations. Of the 1,240 patients, there were 133 in-hospital
deaths observed, giving an overall observed mortality rate of
10.72% (9.09e12.62%). The additive score and logistic score
for the overall group were 7.16% (5.76e8.71%) and 12.88%
(11.11e14.92%), respectively.
Table 2 shows the predictive ability of the logistic Euro-
SCORE in the different surgical subgroups and risk categories.
The values of area under the ROC curve were satisfactory for
all and different types of cardiac surgery, ranging from 0.747
to 0.873, especially in isolated CABG patients group
(AUC ¼ 0.873). For all 1,240 patients, the addictive and
logistic model of EuroSCORE showed excellent accuracy,
with the values of area under the ROC curve 0.839 and 0.845,
respectively (Fig. 1). Good model calibration ability, indicated
by higher p values of the HosmereLemeshow test, was
demonstrated in all categories of patients except for isolated
CABG.
The logistic EuroSCORE predicted a mortality that was
higher than those observed for different operative subgroups and
all risk categories. It means that the logistic EuroSCORE needs
Table 1






Number of patients (n) 1,240 19,030
Age
Mean  SD 62.8  13.87 62.5 10.7 NS
Age group
<60 (yr) 38.4 33.2 <0.001
60e64 (yr) 11.5 17.8 <0.001
65e69 (yr) 13.9 20.7 <0.001
70e74 (yr) 12.2 17.9 <0.001
75 þ (yr) 24.1 9.6 <0.001
Sex, female 29.0 27.8 NS
Chronic pulmonary disease 2.0 3.9 <0.001
Extracardiac arteriopathy 4.4 11.3 <0.001
Neurological dysfunction 6.8 1.4 <0.001
Previous cardiac surgery 3.2 7.3 <0.001
Serum creatinine >200 mmol/L 17.0 1.8 <0.001
Critical pre-operative status 17.5 4.2 <0.001
Unstable angina 42.7 8.0 <0.001
LV dysfunction
LVEF 30e50% 33.5 25.6 <0.001
LVEF <30% 7.7 5.8 <0.001
Recent myocardial infarction 24.0 9.7 <0.001
Pulmonary hypertension 8.4 2.0 <0.001
Emergency 11.5 4.9 <0.001
Other than isolated CABG 54.7 36.4 <0.001
Surgery on thoracic aorta 10.1 2.4 <0.001
Postinfarction septal rupture 0.6 0.2 <0.001
LVEF ¼ left ventricular ejection fraction; NS ¼ non-significant.
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surgery and low to medium-risk groups, and 0.85 for patients
with original additive score more than six.19
Table 3 includes the values of the odds ratios and the values
of b coefficients obtained by multivariate logistic regression
analysis. For VGHKS cardiac surgical patients, having risk
factors such as age, surgery on thoracic aorta, critical pre-
operative status, LVEF<30%, surgery other than isolated
CABG, poor renal function and emergency surgery indicated
significantly greater risk of in-hospital mortality, ranging from
1.03 to 6.48. The b coefficients were estimated directly from
VGHKS cardiac surgical patients (1,240 individuals) based on
the same variables the original EuroSCORE database used.Table 2
Predictive ability of logistic EuroSCORE for different subcategories of patients
No. of patients No. of death Observed MR% (95%
All patients 1,240 133 10.72 (9.09e12.62)
Type of surgery
Isolated CABG 563 32 5.68 (3.98e8.01)
Mitral valve only 150 7 4.67 (2.06e9.75)
Aortic valve only 94 4 4.25 (1.37e11.16)
Rank of riskb
Low (0e2) 133 1 0.75 (0.04e4.74)
Medium (3e5) 370 7 1.89 (0.83e4.03)
High (6e13) 639 78 12.2 (9.82e15.06)
Very high (14þ) 98 47 47.96 (37.85e58.2)
a The HosmereLemeshow statistics.
b ranking by additive EuroSCORE.
AUC ¼ area under the curve; CABG ¼ coronary artery bypass grafting; CI ¼ co4. Discussion
Accurate risk prediction models have assumed an important
role in the practice of modern cardiovascular surgery and have
proven invaluable in surgical decision making, pre-operative
informed consent, quality assurance and healthcare manage-
ment. Between the years of 1995 and 1999, 128 health centers
throughout eight European countries worked to develop the
European system for cardiac operative risk evaluation (Euro-
SCORE), with the aim of predicting 30-day mortality rates of
patients undergoing cardiovascular surgery.2 Risk scoring
systems have reduced applicability when used in patient
populations different from the ones they were formulated on.
In recent years, several studies, including those using meta-
analysis have stated that EuroSCORE is a good discriminative
indicator, but tends to overpredict mortality,8e14 particularly
with regard to aortic valve surgery.20e23
These observations were not astonishing because the Euro-
SCORE model was developed in 15 years ago based on the
patientswho received cardiovascular surgery in 1995. There have
been magnificent improvements in surgical techniques, anes-
thetic and perioperative intensive care quality, all of which have
led to improved surgical results and a reduction in-hospital
mortality. Furthermore, early mortality may increase signifi-
cantly in the first several months versus that within the first
month, especially in patients with comorbidity and postoperative
complications, while the EuroSCORE now only observes the
mortality within 30 days. The different definitions of outcome
such as longer time-span result, patients who cannot discharge
until end-day, and those who needed chronic respiratory care,
might be considered.
Studies concerning the performance of EuroSCORE in
Asian populations were rare. Nevertheless, the results were not
as disappointing as those in Western populations, regardless of
discrimination or calibration.6,11,15,24,25 The results of various
validation studies of EuroSCORE performed in different
countries are summarized in Table 4.5,6,8e12,15,25e27
In Taiwan, Chen et al15 reported an observed mortality rate
of 10.6% in 801 adults patients who received primary or re-
operative CABG, including both off- and on-pump CABG
patients and those who underwent combined procedures duringCI) Predicted MR% (95%CI) O/E pa AUC (95%CI)
12.88 (11.11e14.92) 0.83 0.087 0.845 (0.811e0.880)
10.7 (8.29e13.58) 0.53 0.007 0.873 (0.800e0.945)
8.5 (4.89e14.66) 0.55 0.393 0.747 (0.495e0.998)
7.63 (3.3e15.25) 0.56 0.374 0.856 (0.68e1.031)
1.39 (0.26e5.87) 0.54 0.462 0.212 (0.14e0.284)
3.12 (1.57e5.41) 0.60 0.587 0.605 (0.40e0.81)
14.17 (11.67e17.25) 0.86 0.100 0.75 (0.70e0.80)
56.8 (46.75e67) 0.84 0.145 0.72 (0.622e0.821)













additive EuroSCORE :AUC 0.839 logistic EuroSCORE : AUC 0.845
1 – Specificity 1− Specificity 
Sensitivity Sensitivity
Fig. 1. Receiver operating characteristics curve of addictive and logistic model of EuroSCORE.
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an overall observed mortality rate of 10.72% (9.09e12.62%).
Observed mortality rates were diverse in different surgical
types, while the mortality rate of CABG with or without
combined procedures was 8.21% (data not shown); indicating
that despite the advancement of surgical devices and tech-
niques, patients who received surgeries other than isolated
CABG or isolated valve surgery are still with quite high-risk.
The logistic EuroSCORE demonstrated good discrimina-
tive ability in all and various surgical subgroups (AUCTable 3
Multivariate association of EuroSCORE risk factors with observed mortality in
VGHKS patient population. Ranking according to the OR
Rank Risk factors OR (95% CI) b
coefficient
p
Age (continuous) 1.03 (1.00e1.06) 0.0259 0.0664
1 Surgery on thoracic aorta 6.48 (3.03e13.86) 1.8681 <0.0001
2 Critical pre-operative status 6.35 (3.79e10.62) 1.8476 <0.0001
3 LVEF <30% 5.59 (2.60e12.03) 1.7208 <0.0001
4 Other than isolated CABG 3.59 (1.82e7.09) 1.2791 0.0002
5 Serum creatinine >200
mmol/L
3.28 (1.95e5.51) 1.1874 <0.0001
6 Emergency 2.71 (1.51e4.86) 0.9966 0.0008
7 Recent myocardial
infarction
1.96 (0.91e4.20) 0.6719 0.0848
8 Extracardiac arteriopathy 1.63 (0.60e4.42) 0.4881 0.3376
9 LVEF 30e50% 1.53 (0.80e2.93) 0.4260 0.1972
10 Neurological dysfunction 1.19 (0.53e2.65) 0.1732 0.6721
11 Pulmonary hypertension 1.13 (0.46e2.81) 0.1237 0.7897
12 Postinfarction septal
rupture
1.05 (0.14e8.20) 0.0520 0.9604
13 Active endocarditis 0.98 (0.29e3.38) 0.0171 0.9783
14 Female 0.78 (0.47e1.30) 0.2448 0.3431
15 Unstable angina 0.73 (0.37e1.43) 0.3174 0.3549
16 Previous cardiac surgery 0.66 (0.18e2.40) 0.4175 0.5266
17 Chronic pulmonary
disease
0.37 (0.04e3.40) 0.9843 0.3821
Constant bo 5.2981
CABG ¼ coronary artery bypass grafting; CI ¼ confidence interval;
LVEF ¼ left ventricular ejection fraction; OR ¼ odds ratio.0.75e0.87), compared with those from previous studies in
different countries (AUC 0.64e0.9). The value of AUC indi-
cates an ability of the model to differentiate between patients
who died in-hospital or within 30 days from those who did not.
Most studies, including the present one, demonstrated that the
EuroSCORE model had powerful discriminatory ability (area
under the ROC curve is >0.75). For modern adult cardiovas-
cular surgeries, decision regarding therapeutic option (tradi-
tional open surgery or percutaneous intervention) has
gradually become the leading issue of cost-benefit evaluation.
Therefore, the EuroSCORE model as well may play an
important role in identification of potentially high-risk patients
for some minimally invasive procedures such as transcatheter
aortic valve implantation, when an adequate cut-off point is
defined by more reliable population-based studies.
Calibration tested by HosmereLemeshow chi-square
statistics was satisfactory in all categories of patients ( p value
0.087e0.587) except for isolated CABG ( p value 0.007). The
reasons for this result are unclear and probably multi-factorial.
The epidemiology of ischemic heart disease and comorbidity
in Taiwan may be different from that of the European pop-
ulation. Better access to healthcare in a heavily government-
assisted healthcare system, the National Health Insurance,
which provided earlier, more aggressive investigation and
higher quality medical care (e.g. use of statins), may also have
contributed to the poor calibration performance of the Euro-
SCORE model for the isolated CABG patients group.
Clinical performance of the EuroSCORE model, assessed by
comparing the observed and predicted mortality rates, was dis-
cussed mostly in previous studies because of general over-
estimation. The observed/expected ratio ranged broadly in
different countries (O/E 0.32e1.56). In our study, the logistic
model overpredicted mortality to different degrees in the various
subgroups, ranging from 1.16 times for high-risk group, to 1.89
times for low-risk and uncomplicated surgery group. Differing
casemixes of surgery type and risk category contributes variance
of predicted mortality rate. General medication environment,
health insurance policy and the habits of general population in
Table 4
Discrimination and calibration for the EuroSCORE in different countries
Author Country Surgery Mode No. of patient Observed MR% Predicted MR% O/E AUC pa
Kawachi et al.6 Japan All ADDI 803 e e e 0.82 e
CABG 301 0.89
valve 256 0.9
Nashef et al.5 USA All ADDI 401,684 3.99 3.99 1.00 0.77 e
Bridgewater et al.26 United Kingdom All ADDI 8,572 1.70 3.00 0.57 0.75 e
Chen et al.15 Taiwan CABG ADDI 801 10.60 11.83 0.90 0.75 e
LOGI 11.80 0.90 0.74
Yap et al.8 Australia All ADDI 8,331 3.20 5.31 0.60 0.83 <0.05
LOGI 8.76 0.37 0.83 <0.05
CABG ADDI 5,592 2.00 4.25 0.47 0.82 <0.05
LOGI 6.19 0.32 0.82 <0.05
Bhatti et al.9 United Kingdom All LOGI 9,995 3.30 5.70 0.58 0.79 e
CABG 6,745 2.00 3.90 0.51 0.77
valve 1,523 3.50 7.90 0.44 0.79
Au et al.25 Hong Kong CABG LOGI 1,247 2.90 4.00 0.73 0.76 0.903
valve 1,406 4.80 5.20 0.92 0.77 0.803
D’Errigo et al.10 Italy CABG ADDI 30,610 2.54 2.54 1.00 0.77 0.228
LOGI 6.27 0.40 0.78 <0.001
Zheng et al.11 China CABG LOGI 9,248 3.27 5.51 0.59 0.72 e
CABG 8,120 2.22 4.21 0.53 0.71
Gummert et al.12 Germany CABG LOGI 26,501 2.60 5.18 0.50 0.77 e
Aortic valve 6,305 3.90 7.28 0.53 0.69
Wang et al.27 China Valve ADDI 1,726 4.46 3.51 1.27 0.64 0.204
LOGI 2.85 1.56 0.65 0.038
a The HosmereLemeshow statistics.
ADDI ¼ additive; AUC ¼ area under the curve; CABG ¼ coronary artery bypass grafting; LOGI ¼ logistic; MR ¼ mortality rate; O/E ¼ observed/expected ratio.
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explain the wide range of observed/expected ratio.
In VGHKS cardiovascular surgical patients, multivariate
logistic regression analysis revealed seven factors to be signifi-
cant predictors of in-hospital mortality, including elder, critical
pre-operative condition, emergent operation, surgery on thoracic
aorta, other than isolated CABG, poor left ventricular ejection
fraction and serum creatinine >2.26 mg/dL. On the contrary,
patients with the factor of active endocarditis, female, unstable
angina, previous cardiac surgery and COPD inversely predicted
the risk of mortality, yet the associations were not statistically
significant.
We have assessed the predictive ability of the EuroSCORE
on cardiovascular surgery populations in the southern Taiwan,
and have given useful contemporary calibration figures for the
various operative subgroups and risk categories. However, the
data was from single-institutional study, in which the number
of patients who underwent isolated aortic valve surgery were
few, while it is mainly focused on in recent studies. Further-
more, our data have not been validated externally, which is
also a weakness of our study.
Although patients with severe left ventricular dysfunction had
higher mortality and morbidity, CABG is recommended be done
in these high-risk patients with acceptable results.28 On the other
hand, surgical repair of acute postinfarction ventricular septal
defect with a endocardial patch and infarction exclusion method
will improve the overall mortality.29
In conclusion, the EuroSCORE model demonstrated
excellent accuracy in all and various surgical subgroups in
VGHKS cardiovascular surgery populations. Good calibrationability in all and different risk categories was identified except
for isolated CABG group. On the other hand, the model
overpredicted mortality to different degrees at all risk levels; it
means that the logistic EuroSCORE needs to be recalibrated
by a factor of about 0.55 for uncomplicated surgery and low-
risk to medium-risk groups, and 0.85 for high-risk patients
with original additive score more than six.
Furthermore, our institution has participated in new data
collection for EuroSCORE 2010,30 broader physical and bio-
logical records, more detailed surgical definitions and different
clinical outcomes were collected for this new model. The
wider involvement of cardiovascular surgery population of
various institutions in Taiwan, to evaluate the specific
cardiovascular surgical risks for Taiwanese, will be the focus
of future investigations.
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